ASM Technologies Ltd has announced a preferential issue of 10,78,974 equity shares to raise approximately Rs 526 crore. Key investors include SBI Mutual Fund and SBI Emergent India Fund, who are participating alongside other entities. The issue price is set at Rs 4,875 per share, including a premium of Rs 4,865. The company will seek shareholder approval for this fundraising through an Extra-Ordinary General Meeting scheduled for October 4, 2026. This capital injection underscores strong institutional interest but will result in equity dilution for existing shareholders.
ASM Technologies Announces Rs 526 Crore Preferential Share Issuance
ASM Technologies will raise Rs 525.99 crore through the issuance of 10,78,974 equity shares at Rs 4,875 per share.
Reader Takeaway: Strong institutional backing boosts capital, though existing shareholders face equity dilution pending upcoming EGM approval.
What just happened
The Board of Directors of ASM Technologies Ltd approved a preferential equity issue in their meeting on September 9, 2026. The company intends to raise Rs 525.99 crore by issuing 10,78,974 shares at a premium of Rs 4,865 per share (Face Value Rs 10). The funds will be raised entirely through cash consideration.
Why this matters
This fundraising marks a major capital inflow for the company. The participation of marquee institutional investors like SBI Mutual Fund and SBI Emergent India Fund indicates confidence in the company’s growth trajectory. The proceeds are expected to strengthen the company’s balance sheet and support future operations.
Allottees
- SBI Mutual Fund: 8,22,564 shares (approx. Rs 401 crore)
- SBI Emergent India Fund: 1,02,564 shares (approx. Rs 50 crore)
- Derive Trading and Resorts Pvt Ltd: 1,02,564 shares (approx. Rs 50 crore)
- Asha Mukul Agrawal: 51,282 shares (approx. Rs 25 crore)
Next steps
The company has scheduled an Extra-Ordinary General Meeting (EGM) for October 4, 2026, at 10:00 a.m. via video conferencing to obtain shareholder approval. The floor price was determined based on the regulatory date of September 4, 2026.
Risks to watch
Existing shareholders should note that this issuance will lead to the dilution of current equity stakes. The final allotment remains contingent upon the outcome of the EGM and regulatory compliance.